These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 37176153)

  • 21. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology.
    Memaj P; Jornayvaz FR
    Front Endocrinol (Lausanne); 2022; 13():1031633. PubMed ID: 36531463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic Mediators of Lipid Metabolism and Ketogenesis: Focus on Fatty Liver and Diabetes.
    Fernandes GW; Bocco BMLC
    Curr Diabetes Rev; 2021; 17(7):e110320187539. PubMed ID: 33143628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triglyceride to high-density lipoprotein cholesterol ratio is an independent predictor of liver fibrosis among pediatrics non-alcoholic fatty liver disease.
    Ting YW; Jalaludin MY; Zaini AA; Mohamed R
    Front Endocrinol (Lausanne); 2022; 13():1071350. PubMed ID: 36589844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause.
    Robeva R; Mladenović D; Vesković M; Hrnčić D; Bjekić-Macut J; Stanojlović O; Livadas S; Yildiz BO; Macut D
    Maturitas; 2021 Sep; 151():22-30. PubMed ID: 34446275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity.
    Wang R; Yang F; Qing L; Huang R; Liu Q; Li X
    Clin Obes; 2019 Feb; 9(1):e12289. PubMed ID: 30411515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions.
    Ore A; Akinloye OA
    Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology.
    Zhao J; Lei H; Wang T; Xiong X
    Front Endocrinol (Lausanne); 2023; 14():1161402. PubMed ID: 36967758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity.
    Peña-Vélez R; Garibay-Nieto N; Cal-Y-Mayor-Villalobos M; Laresgoiti-Servitje E; Pedraza-Escudero K; García-Blanco MDC; Heredia-Nieto OA; Villanueva-Ortega E
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):205-213. PubMed ID: 31846425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
    Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
    Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic inflexibility and insulin resistance in obese adolescents with non-alcoholic fatty liver disease.
    Lee S; Rivera-Vega M; Alsayed HM; Boesch C; Libman I
    Pediatr Diabetes; 2015 May; 16(3):211-8. PubMed ID: 24754380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".
    Fang YL; Chen H; Wang CL; Liang L
    World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity.
    Liu LJ; Kang YR; Xiao YF
    World J Pediatr; 2021 Aug; 17(4):394-399. PubMed ID: 34370215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Adams LA; Anstee QM; Tilg H; Targher G
    Gut; 2017 Jun; 66(6):1138-1153. PubMed ID: 28314735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum.
    Fitzpatrick E
    Proc Nutr Soc; 2019 Aug; 78(3):362-371. PubMed ID: 30732664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?
    Firneisz G
    World J Gastroenterol; 2014 Jul; 20(27):9072-89. PubMed ID: 25083080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
    Milić S; Lulić D; Štimac D
    World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.